Benzinga | Jun 15, 2021 06:09AM EDT

HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and raises the price target from $17 to $25.